{"entity":{"type":"insider","cik":"0001276750","url":"/insider/0001276750","json_url":"/insider/0001276750.json","name":"KIRSKE DAVID","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":8,"first":"2022-06-16","last":"2026-07-01","span_basis":"filed_date"},"name_variants":[{"name":"KIRSKE DAVID","source":"filing","n_filings":8,"first_seen":"2022-06-16","last_seen":"2026-07-01"}],"transactions":[{"id":6038799,"accession":"0001501697-26-000065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001501697-26-000065","line_url":"/filing/0001501697-26-000065#line-1","is_derivative":false,"issuer_cik":"0001276750","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001276750","owner_cik":"0001276750","owner_name":"KIRSKE DAVID","owner_display_name":"KIRSKE DAVID","owner_url":"/insider/0001276750","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8543.0,"shares_display":"8,543","price_per_share":4.2641,"price_display":"4.26","price_state":"stated","total_value":36428.2063,"total_display":"36,428.21","total_whole":"36,428","shares_owned_after":167750.0,"shares_owned_after_display":"167,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-30","filed_date":"2026-07-01","scope":"insider"},{"id":6148668,"accession":"0001501697-26-000049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001501697-26-000049","line_url":"/filing/0001501697-26-000049#line-1","is_derivative":false,"issuer_cik":"0001276750","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001276750","owner_cik":"0001276750","owner_name":"KIRSKE DAVID","owner_display_name":"KIRSKE DAVID","owner_url":"/insider/0001276750","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16961.0,"shares_display":"16,961","price_per_share":4.2934,"price_display":"4.29","price_state":"stated","total_value":72820.3574,"total_display":"72,820.36","total_whole":"72,820","shares_owned_after":176293.0,"shares_owned_after_display":"176,293","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-12","filed_date":"2026-05-13","scope":"insider"},{"id":7938808,"accession":"0000891293-23-000001","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000891293-23-000001","line_url":"/filing/0000891293-23-000001#line-11","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001276750","owner_name":"KIRSKE DAVID","owner_display_name":"KIRSKE DAVID","owner_url":"/insider/0001276750","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27021.0,"shares_display":"27,021","price_per_share":6.011,"price_display":"6.01","price_state":"stated","total_value":162423.231,"total_display":"162,423.23","total_whole":"162,423","shares_owned_after":17127.0,"shares_owned_after_display":"17,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-03","scope":"insider"},{"id":7938804,"accession":"0000891293-23-000001","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000891293-23-000001","line_url":"/filing/0000891293-23-000001","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001276750","owner_name":"KIRSKE DAVID","owner_display_name":"KIRSKE DAVID","owner_url":"/insider/0001276750","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13847.0,"shares_display":"13,847","price_per_share":6.001044991694952,"price_display":"6.00","price_state":"stated","total_value":83096.47,"total_display":"83,096.47","total_whole":"83,096","shares_owned_after":17127.0,"shares_owned_after_display":"17,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-30","filed_date":"2023-01-03","scope":"insider","n_lines":3},{"id":7938791,"accession":"0000891293-23-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000891293-23-000001","line_url":"/filing/0000891293-23-000001#line-2","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001276750","owner_name":"KIRSKE DAVID","owner_display_name":"KIRSKE DAVID","owner_url":"/insider/0001276750","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13174.0,"shares_display":"13,174","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":79044.0,"total_display":"79,044.00","total_whole":"79,044","shares_owned_after":16913.0,"shares_owned_after_display":"16,913","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-29","filed_date":"2023-01-03","scope":"insider"},{"id":6138668,"accession":"0000891293-22-000047","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000891293-22-000047","line_url":"/filing/0000891293-22-000047","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001276750","owner_name":"KIRSKE DAVID","owner_display_name":"KIRSKE DAVID","owner_url":"/insider/0001276750","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2109.0,"shares_display":"2,109","price_per_share":6.256249407302039,"price_display":"6.26","price_state":"stated","total_value":13194.43,"total_display":"13,194.43","total_whole":"13,194","shares_owned_after":16913.0,"shares_owned_after_display":"16,913","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-04","filed_date":"2022-10-06","scope":"insider","n_lines":3},{"id":6234467,"accession":"0000891293-22-000046","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000891293-22-000046","line_url":"/filing/0000891293-22-000046#line-8","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001276750","owner_name":"KIRSKE DAVID","owner_display_name":"KIRSKE DAVID","owner_url":"/insider/0001276750","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":6.25,"price_display":"6.25","price_state":"stated","total_value":1875.0,"total_display":"1,875.00","total_whole":"1,875","shares_owned_after":16913.0,"shares_owned_after_display":"16,913","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-03","scope":"insider"},{"id":6234460,"accession":"0000891293-22-000046","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000891293-22-000046","line_url":"/filing/0000891293-22-000046#line-6","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001276750","owner_name":"KIRSKE DAVID","owner_display_name":"KIRSKE DAVID","owner_url":"/insider/0001276750","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":139841.0,"shares_display":"139,841","price_per_share":6.0465,"price_display":"6.05","price_state":"stated","total_value":845548.6065,"total_display":"845,548.61","total_whole":"845,549","shares_owned_after":16913.0,"shares_owned_after_display":"16,913","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-30","filed_date":"2022-10-03","scope":"insider"},{"id":6234453,"accession":"0000891293-22-000046","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000891293-22-000046","line_url":"/filing/0000891293-22-000046","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001276750","owner_name":"KIRSKE DAVID","owner_display_name":"KIRSKE DAVID","owner_url":"/insider/0001276750","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":6.001111111111111,"price_display":"6.00","price_state":"stated","total_value":5401.0,"total_display":"5,401.00","total_whole":"5,401","shares_owned_after":16913.0,"shares_owned_after_display":"16,913","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-29","filed_date":"2022-10-03","scope":"insider","n_lines":2},{"id":6587169,"accession":"0000891293-22-000045","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000891293-22-000045","line_url":"/filing/0000891293-22-000045#line-3","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001276750","owner_name":"KIRSKE DAVID","owner_display_name":"KIRSKE DAVID","owner_url":"/insider/0001276750","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22592.0,"shares_display":"22,592","price_per_share":6.02,"price_display":"6.02","price_state":"stated","total_value":136003.84,"total_display":"136,003.84","total_whole":"136,004","shares_owned_after":16913.0,"shares_owned_after_display":"16,913","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-16","filed_date":"2022-09-20","scope":"insider"},{"id":6875634,"accession":"0000891293-22-000033","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000891293-22-000033","line_url":"/filing/0000891293-22-000033","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001276750","owner_name":"KIRSKE DAVID","owner_display_name":"KIRSKE DAVID","owner_url":"/insider/0001276750","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":6.2084166666666665,"price_display":"6.21","price_state":"stated","total_value":372505.0,"total_display":"372,505.00","total_whole":"372,505","shares_owned_after":7397.0,"shares_owned_after_display":"7,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-17","filed_date":"2022-06-17","scope":"insider","n_lines":2},{"id":6501824,"accession":"0000891293-22-000032","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000891293-22-000032","line_url":"/filing/0000891293-22-000032#line-2","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001276750","owner_name":"KIRSKE DAVID","owner_display_name":"KIRSKE DAVID","owner_url":"/insider/0001276750","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":55000.0,"total_display":"55,000.00","total_whole":"55,000","shares_owned_after":7397.0,"shares_owned_after_display":"7,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-14","filed_date":"2022-06-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001501697","name":"X4 Pharmaceuticals, Inc","url":"/issuer/0001501697","role":"Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2026-05-13","last_seen":"2026-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0000891293","name":"CTI BIOPHARMA CORP","url":"/issuer/0000891293","role":"Officer (EVP, Chief Financial Officer)","n_filings":6,"first_seen":"2022-06-16","last_seen":"2023-01-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001276750","retrieved_at":"2026-08-24T14:45:04+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}